• Back to miR-16-5p

• Humplikova, Lenka, et al. "Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemia." Biomedical Papers 157.4 (2013): 284-293.
• Mobarra, Naser, et al. "Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells." In Vitro Cellular & Developmental Biology-Animal 51.6 (2015): 604-611.
• Zhu, Yi, et al. "MiR-16 induced the suppression of cell apoptosis while promote proliferation in esophageal squamous cell carcinoma." Cellular Physiology and Biochemistry 33.5 (2014): 1340-1348.
• Fu, Xiafei, et al. "MicroRNA-16 Promotes Ovarian Granulosa Cell Proliferation and Suppresses Apoptosis Through Targeting PDCD4 in Polycystic Ovarian Syndrome." Cellular Physiology and Biochemistry 48.2 (2018): 670-682.
• Bonci, Désirée, et al. "The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities." Nature medicine 14.11 (2008): 1271.
• Jiao, Z. H., J. D. Wang, and X. J. Wang. "MicroRNA-16 suppressed the invasion and migration of osteosarcoma by directly inhibiting RAB23." European review for medical and pharmacological sciences 22.9 (2018): 2598-2605.
• Bandi, Nora, et al. "miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non–small cell lung cancer." Cancer research 69.13 (2009): 5553-5559.
• Chen, Duqun, et al. "Upregulated microRNA-16 as an oncogene in renal cell carcinoma." Molecular medicine reports 12.1 (2015): 1399-1404.
• Zhang, Huidi, et al. "B cell-related circulating microRNAs with the potential value of biomarkers in the differential diagnosis, and distinguishment between the disease activity and lupus nephritis for SLE." Frontiers in immunology 9 (2018): 1473.
• Dunaeva, Marina, et al. "Circulating serum miR‐223‐3p and miR‐16‐5p as possible biomarkers of early rheumatoid arthritis." Clinical & Experimental Immunology (2018).